<VariationArchive VariationID="165160" VariationName="NM_000335.5(SCN5A):c.255del (p.Phe86fs)" VariationType="Deletion" Accession="VCV000165160" Version="8" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-05" DateCreated="2015-02-02" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="173793" VariationID="165160">
      <GeneList>
        <Gene Symbol="SCN5A" FullName="sodium voltage-gated channel alpha subunit 5" GeneID="6331" HGNC_ID="HGNC:10593" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="38548062" stop="38649687" display_start="38548062" display_stop="38649687" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="38589552" stop="38691163" display_start="38589552" display_stop="38691163" Strand="-" />
          </Location>
          <OMIM>600163</OMIM>
          <Haploinsufficiency last_evaluated="2021-06-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN5A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-06-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN5A">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000335.5(SCN5A):c.255del (p.Phe86fs)</Name>
      <CanonicalSPDI>NC_000003.12:38633052:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="38633053" stop="38633053" display_start="38633053" display_stop="38633053" variantLength="1" positionVCF="38633052" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="38674544" stop="38674544" display_start="38674544" display_stop="38674544" variantLength="1" positionVCF="38674543" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>F86fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198056.2" sequenceAccession="NM_198056" sequenceVersion="2" change="c.255delC">
            <Expression>NM_198056.2:c.255delC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_289" sequenceAccession="LRG_289">
            <Expression>LRG_289:g.21620del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.38674547del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.38674547del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.38633056del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.38633056del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008934.1" sequenceAccession="NG_008934" sequenceVersion="1" change="g.21620del">
            <Expression>NG_008934.1:g.21620del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000335.5" sequenceAccession="NM_000335" sequenceVersion="5" change="c.255del" MANESelect="true">
            <Expression>NM_000335.5:c.255del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000326.2" sequenceAccession="NP_000326" sequenceVersion="2" change="p.Phe86fs">
            <Expression>NP_000326.2:p.Phe86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099404.2" sequenceAccession="NM_001099404" sequenceVersion="2" change="c.255del" MANEPlusClinical="true">
            <Expression>NM_001099404.2:c.255del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001092874.1" sequenceAccession="NP_001092874" sequenceVersion="1" change="p.Phe86fs">
            <Expression>NP_001092874.1:p.Phe86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099405.2" sequenceAccession="NM_001099405" sequenceVersion="2" change="c.255del">
            <Expression>NM_001099405.2:c.255del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001092875.1" sequenceAccession="NP_001092875" sequenceVersion="1" change="p.Phe86fs">
            <Expression>NP_001092875.1:p.Phe86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160160.2" sequenceAccession="NM_001160160" sequenceVersion="2" change="c.255del">
            <Expression>NM_001160160.2:c.255del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153632.1" sequenceAccession="NP_001153632" sequenceVersion="1" change="p.Phe86fs">
            <Expression>NP_001153632.1:p.Phe86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160161.2" sequenceAccession="NM_001160161" sequenceVersion="2" change="c.255del">
            <Expression>NM_001160161.2:c.255del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153633.1" sequenceAccession="NP_001153633" sequenceVersion="1" change="p.Phe86fs">
            <Expression>NP_001153633.1:p.Phe86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354701.2" sequenceAccession="NM_001354701" sequenceVersion="2" change="c.255del">
            <Expression>NM_001354701.2:c.255del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341630.1" sequenceAccession="NP_001341630" sequenceVersion="1" change="p.Phe86fs">
            <Expression>NP_001341630.1:p.Phe86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198056.3" sequenceAccession="NM_198056" sequenceVersion="3" change="c.255del">
            <Expression>NM_198056.3:c.255del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_932173.1" sequenceAccession="NP_932173" sequenceVersion="1" change="p.Phe86fs">
            <Expression>NP_932173.1:p.Phe86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA016281" DB="ClinGen" />
        <XRef Type="rs" ID="727503411" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000335.5(SCN5A):c.255del (p.Phe86fs) AND Brugada syndrome" Accession="RCV000151808" Version="7">
        <ClassifiedConditionList TraitSetID="9317">
          <ClassifiedCondition DB="MedGen" ID="C1142166">Brugada syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2014-01-31" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000335.5(SCN5A):c.255del (p.Phe86fs) AND not provided" Accession="RCV003764927" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-29" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-02-02" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20129283</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22789973</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9317" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16748" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Sudden unexplained nocturnal death syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sudden Unexplained Death Syndrome</ElementValue>
                <XRef ID="D053840" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sudden Unexplained Nocturnal Death Syndrome (SUNDS)</ElementValue>
                <XRef ID="D053840" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Brugada syndrome</ElementValue>
                <XRef ID="Brugada+Syndrome/982" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015263" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS601144" DB="OMIM" />
                <XRef ID="418818005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sudden unexpected nocturnal death syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SUNDS</ElementValue>
                <XRef Type="MIM" ID="601144" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BrS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1030" />
                <XRef ID="1030" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Brugada syndrome is characterized by cardiac conduction abnormalities (ST segment abnormalities in leads V1-V3 on EKG and a high risk for ventricular arrhythmias) that can result in sudden death. Brugada syndrome presents primarily during adulthood, although age at diagnosis may range from infancy to late adulthood. The mean age of sudden death is approximately 40 years. Clinical presentations may also include sudden infant death syndrome (SIDS; death of a child during the first year of life without an identifiable cause) and sudden unexpected nocturnal death syndrome (SUNDS), a typical presentation in individuals from Southeast Asia. Other conduction defects can include first-degree AV block, intraventricular conduction delay, right bundle branch block, and sick sinus syndrome.</Attribute>
                <XRef ID="NBK1517" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301690</ID>
                <ID Source="BookShelf">NBK1517</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <XRef ID="130" DB="Orphanet" />
              <XRef ID="C1142166" DB="MedGen" />
              <XRef ID="MONDO:0015263" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS601144" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="358221" SubmissionDate="2019-03-21" DateLastUpdated="2015-02-02" DateCreated="2015-02-02">
        <ClinVarSubmissionID localKey="42394163|Orphanet:ORPHA130" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000200274" DateUpdated="2015-02-02" DateCreated="2015-02-02" Type="SCV" Version="5" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The Phe86fs variant in SCN5A has not been previously reported in individuals wit h cardiomyopathy or in large population studies. This variant is predicted to c ause a frameshift, which alters the protein's amino acid sequence beginning at c odon 86 and leads to a premature stop codon 11 codons downstream. This alterati on is then predicted to lead to a truncated or absent protein. Heterozygous loss of function variants in the SCN5A gene have been reported in individuals with B rugada syndrome (Kapplinger 2010), DCM (Olson 2005), ventricular fibrillation (C hen 1998), as well as AV block and cardiac conduction defects (Baruteau 2012) bu t it is not clear if all variants of this type cause disease. In summary, this variant is very likely pathogenic but additional evidence is needed to establish this with certainty.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_198056.2:EXON 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_198056.2:c.255delC</Name>
            <Name>p.Phe86SerfsX11</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.38674544delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA130" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348979</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4236454" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13613920|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002225441" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20129283</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22789973</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 165160). This variant has not been reported in the literature in individuals affected with SCN5A-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe86Serfs*11) in the SCN5A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCN5A are known to be pathogenic (PMID: 20129283, 22789973).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.38674544del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="358221" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA130" MappingRef="Orphanet">
        <MedGen CUI="C1142166" Name="Brugada syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4236454" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

